Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk B | Copenhagen | Healthcare | Pharmaceuticals | DKK 1.59T | 14.3x | 0.59 | DKK 358.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.6% Upside | Upgrade to Pro+ | |
Coloplast | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 138.16B | 34x | -1.85 | DKK 612.80 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.9% Upside | Upgrade to Pro+ | |
Genmab | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 97.67B | 11.4x | 0.14 | DKK 1,588 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.1% Upside | Upgrade to Pro+ | |
Demant | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 51.98B | 19.6x | -19.7 | DKK 244 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
ALK-Abello B | Copenhagen | Healthcare | Pharmaceuticals | DKK 44.50B | 45x | 1.15 | DKK 201.20 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.1% Downside | Upgrade to Pro+ | |
H Lundbeck B | Copenhagen | Healthcare | Pharmaceuticals | DKK 38.60B | 11.1x | 0.31 | DKK 40.34 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.6% Upside | Upgrade to Pro+ | |
H Lundbeck AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 38.60B | 11.1x | 0.31 | DKK 33.35 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zealand Pharma | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 30.78B | 4.6x | 0 | DKK 437.40 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ambu | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 25.64B | 72x | -3.65 | DKK 96.30 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.3% Upside | Upgrade to Pro+ | |
Bavarian Nordic | Copenhagen | Healthcare | Pharmaceuticals | DKK 18.42B | 13.1x | 0.13 | DKK 236.60 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.1% Upside | Upgrade to Pro+ | |
Embla Medical hf | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 13.20B | 29.2x | 1.43 | DKK 31 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.5% Upside | Upgrade to Pro+ | |
ChemoMetec | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 9.07B | 53.5x | 2.99 | DKK 521 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.8% Upside | Upgrade to Pro+ | |
Gubra AS | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 5.76B | 3.6x | 0 | DKK 375.20 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
BioPorto | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 583.78M | -6.6x | 0.14 | DKK 1.28 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Scandinavian Medical Solutions AS | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 115.18M | 48.3x | -0.88 | DKK 4.16 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ViroGates | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 73.63M | -5.8x | -0.29 | DKK 9.52 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bactiquant AS | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 60.04M | DKK 2.56 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Stenocare AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 51.56M | -1.2x | 0.04 | DKK 1.35 | 9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Strategic Partners AS | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 43.17M | -128.9x | -1.47 | DKK 1,000.83 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |